Polyclonal antibodies, from sheep or rabbit, have been widely used from the 90s, in Immunoassays. While polyclonal antibodies are simple and inexpensive to produce, they usually lack specificity and suffer from batch to batch variability. Monoclonal antibody production requires high skills and is more expensive. However, a careful selection process ensures a superior specificity profile. Moreover, state of the art production techniques ensure a constant and renewable source of antibodies and all batches are identical.
The DIAsource Antibodies are produced in-house and purified using cutting-edge technologies. The use of these antibodies in DIAsource RIA and ELISA immunoassays guarantees a high quality and uncompromising quality control.
Our antibody product range covers areas such as Bone Metabolism, Cancer, Cardiovascular diseases, Diabetes & Metabolism, Fertility, Growth Factors and Thyroid Function areas.
- Large scale production in bioreactors
- Very good lot-to-lot consistency
- Fast delivery
- Custom formats
- Interesting pricing for high volumes
- Experienced technical support
In 2009, DIAsource Immunoassays has patented Mouse Monoclonal Antibodies, based on a proprietary Vitamin D hapten, recognizing both 25OH Vitamin D3 and 25OH Vitamin D2. The patent was granted in Europe in 2013 and is pending in the US. The patent covers any monoclonal antibody recognizing both 25OH Vitamin D3 and 25OH Vitamin D2. These monoclonal antibodies have been successfully used in commercial RIA (RadioImmunoAssay), ELISA (Enzyme-Linked ImmunoSorbent Assay), CLIA (ChemiLuminescence ImmunoAssay) and POCT (Point Of Care Test), by DIAsource Immunoassays or by DIAsource partners.